IMPROVEMENT WITH DULOXETINE IN PRIMARY PROGRESSIVE FREEZING GAITMORGANTE, Francesca; FASANO, Alfonso.Neurology. 2010, Vol 75, Num 23, pp 2130-2132, issn 0028-3878, 3 p.Article

Stress Degradation Studies and Kinetic Determinations of Duloxetine Enteric-Coated Pellets by HPLCGOMES, Patricia; WINGERT, Nathalie R; PAIM, Clésio S et al.Journal of AOAC International. 2010, Vol 93, Num 6, pp 1829-1835, issn 1060-3271, 7 p.Article

Stability-Indicating RP-HPLC Method Development and Validation for Duloxetine Hydrochloride in TabletsPATEL, Sejal K; PATEL, Natavarlal J; PRAJAPATI, Arun M et al.Journal of AOAC International. 2010, Vol 93, Num 1, pp 123-132, issn 1060-3271, 10 p.Article

Highly enantioselective bioreduction of N-methyl-3-oxo-3-(thiophen-2-yl) propanamide for the production of (S)-duloxetineTANG, Chuan-Gen; HUI LIN; CHAO ZHANG et al.Biotechnology letters. 2011, Vol 33, Num 7, pp 1435-1440, issn 0141-5492, 6 p.Article

Open-Label Support for Duloxetine for the Treatment of Panic DisorderSIMON, Naomi M; KAUFMAN, Rebecca E; HOGE, Elizabeth A et al.CNS neuroscience & therapeutics (Print). 2009, Vol 15, Num 1, pp 19-23, issn 1755-5930, 5 p.Article

Attributes of response in depressed patients switched to treatment with duloxetineSAGMAN, D; MCINTOSH, D; LEE, M. S et al.International journal of clinical practice (Esher). 2011, Vol 65, Num 1, pp 73-81, issn 1368-5031, 9 p.Article

Severe INR Elevation Related to Duloxetine Use: A Case ReportGIMENEZ, Clifford; GUCE, Garry; LINGISETTY, Chandra et al.Psychosomatics (Washington, DC). 2011, Vol 52, Num 6, pp 583-585, issn 0033-3182, 3 p.Article

Tolerability and efficacy of duloxetine in a nontrial situationDUCKETT, J. R. A; VELLA, M; KAVALAKUNTLA, G et al.BJOG (Oxford. Print). 2007, Vol 114, Num 5, pp 543-547, issn 1470-0328, 5 p.Article

Intérêt de la duloxétine (cymbalta®) en pratique clinique quotidienneCONSTAN, E. L.Louvain médical. 2007, Vol 126, Num 1, pp 35-38, issn 0024-6956, 4 p.Article

Block of Neuronal Na⁺ Channels by Antidepressant Duloxetine in a State-dependent MannerWANG, Sho-Ya; CALDERON, Joanna; GING KUO WANG et al.Anesthesiology (Philadelphia). 2010, Vol 113, Num 3, pp 655-665, issn 0003-3022, 11 p.Article

A Case of Milnacipran-Related Sweating Alleviated by Duloxetine SubstitutionWU, Chia-Cheng; CHANG, Jane Pei-Chen; LIOU, Jiunn-Shean et al.Journal of clinical psychopharmacology. 2010, Vol 30, Num 5, pp 640-641, issn 0271-0749, 2 p.Article

Duloxetine-Associated TachycardiaSTEVENS, Debra L.The Annals of pharmacotherapy. 2008, Vol 42, Num 10, pp 1511-1513, issn 1060-0280, 3 p.Article

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic painWERNICKE, J. F; PRITCHETT, Y. L; D'SOUZA, D. N et al.Neurology. 2006, Vol 67, Num 8, pp 1411-1420, issn 0028-3878, 10 p.Article

The Efficacy and Safety of Duloxetine in a Multidrug Regimen for Chronic Prostatitis/Chronic Pelvic Pain SyndromeGIANNANTONI, Antonella; PORENA, Massimo; GUBBIOTTI, Marilena et al.Urology (Ridgewood, NJ). 2014, Vol 83, Num 2, pp 400-405, issn 0090-4295, 6 p.Article

Use of Serotonin Norepinephrine Reuptake Inhibitors in the Treatment of Attention-Deficit Hyperactivity Disorder in PediatricsPARK, Pauline; CABALLERO, Joshua; OMIDIAN, Hossein et al.The Annals of pharmacotherapy. 2014, Vol 48, Num 1, pp 86-92, issn 1060-0280, 7 p.Article

Development of chiral methodologies by capillary electrophoresis with ultraviolet and mass spectrometry detection for duloxetine analysis in pharmaceutical formulationsSANCHEZ-LOPEZ, Elena; MONTEALEGRE, Cristina; MARINA, María Luisa et al.Journal of chromatography. 2014, Vol 1363, pp 356-362, issn 0021-9673, 7 p.Article

Application of the Gradient Boosted method in randomised clinical trials: Participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placeboDODD, Seetal; BERK, Michael; KELIN, Katarina et al.Journal of affective disorders. 2014, Vol 168, pp 284-293, issn 0165-0327, 10 p.Article

Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trialALAKA, Karla J; NOBLE, William; BALL, Susan et al.International journal of geriatric psychiatry. 2014, Vol 29, Num 9, pp 978-986, issn 0885-6230, 9 p.Article

Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorderBOULENGER, Jean-Philippe; LOFT, Henrik; OLSEN, Christina Kurre et al.International clinical psychopharmacology. 2014, Vol 29, Num 3, pp 138-149, issn 0268-1315, 12 p.Article

Duloxetine: withdrawal syndromesPrescrire international (Paris). 2013, Vol 22, Num 142, pp 243-244, issn 1167-7422, 2 p.Article

Evaluation of the enantioselectivity of glycogen-based synergistic system with amino acid chiral ionic liquids as additives in capillary electrophoresisQI ZHANG; YINGXIANG DU.Journal of chromatography. 2013, Vol 1306, pp 97-103, issn 0021-9673, 7 p.Article

Brain-derived neurotrophic factor in generalized anxiety disorder: Results from a duloxetine clinical trialBALL, Susan; MARANGELL, Lauren B; LIPSIUS, Sarah et al.Progress in neuro-psychopharmacology & biological psychiatry. 2013, Vol 43, pp 217-221, issn 0278-5846, 5 p.Article

Glucocorticoid Receptor and FKBP5 Expression Is Altered Following Exposure to Chronic Stress: Modulation by Antidepressant TreatmentGUIDOTTI, Gianluigi; CALABRESE, Francesca; ANACKER, Christoph et al.Neuropsychopharmacology (New York, NY). 2013, Vol 38, Num 4, pp 616-627, issn 0893-133X, 12 p.Article

NGF serum levels variations in major depressed patients receiving duloxetineMARTINO, Matteo; ROCCHI, Giulio; ESCELSIOR, Andrea et al.Psychoneuroendocrinology. 2013, Vol 38, Num 9, pp 1824-1828, issn 0306-4530, 5 p.Article

Pharmacokinetic Analysis of Two Different Doses of Duloxetine Following Oral Administration in DogsBAEK, I.-H; LEE, B.-Y; KANG, W et al.Drug research (Stuttgart. 2013. Print). 2013, Vol 63, Num 8, pp 404-408, issn 2194-9379, 5 p.Article